Table 4.
Feature | m-NAD(P)-ME | PFK-1 |
---|---|---|
Subcellular Location | Mitochondria | Cytosol |
Quaternary Structure |
Tetramer (most active) Dimer (less active) |
Tetramer (most active) Dimer (less active) |
Allosteric Nucleotide-binding Site |
One site Exosite at the tetramer interface; can bind to NAD+, ATP or ADP22–24,27,28 NAD+ binding: Enhances the formation of a tetrameric structure ATP binding: Promotes the dissociation of tetramers into dimers |
Two sites Activating nucleotide-binding site can bind to ADP or AMP. Inhibitory nucleotide-binding site can bind to ATP or ADP. ATP binding: Promotes the dissociation of tetramers into dimers42,43 |
Nucleotide Substrate | NAD+ | ATP (<1 mM) |
Nucleotide Inhibitor |
ATP (IC50 = 0.2 mM) ADP (IC50 = 3.7 mM) tetramers disassociate into dimers |
ATP (>1 mM) ADP (at mM) tetramers disassociate into dimers |
Nucleotide Activator | NAD+ | ADP (at μM) |